UNSPSC 51351608: Estriol

This classification denotes a steroidal estrogen with the molecular formula C18H24O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FB33469R8E, chemically known as 3,16beta,17beta-trihydroxy-1,3,5(10)-estratriene but generally known as estriol, which bears US NIH Compound Identifier 3269. European Medicines Agency schedules Estriol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01971MIG. World Health Organization schedules estriol in its Anatomical Therapeutic Chemical (ATC) Classification.

UNSPSC 51351608 Estriol, a Commodity code, represents a niche pharmaceutical product with minimal recent state and local procurement activity. Estriol is a form of estrogen used in hormone replacement therapy and other clinical applications; state and local health agencies, public hospitals, and managed-care entities occasionally procure it through pharmaceutical supply contracts, though it does not appear as a standalone line item in most routine solicitations. The work typically involves bulk pharmaceutical supply, warehousing, and delivery rather than manufacturing or compounding.

No recent state and local contract opportunities appear in the available records for this code. Given the specialized nature of estriol and its narrow clinical use, procurement under this Commodity code is sporadic and often embedded within broader pharmaceutical or medical-supply agreements rather than issued as standalone RFPs or RFQs. Firms pursuing activity in this space should monitor general pharmaceutical supply solicitations from state health departments, university hospital systems, and large county medical centers rather than expect dedicated estriol-specific notices.